Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Certara Inc
(NQ:
CERT
)
17.88
+0.26 (+1.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
632,713
Open
17.70
Bid (Size)
17.88 (1)
Ask (Size)
18.25 (10)
Prev. Close
17.62
Today's Range
17.70 - 18.48
52wk Range
11.81 - 24.96
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Scoreboard: 4 Ratings For Certara
March 01, 2024
Via
Benzinga
Certara Reports Fourth Quarter 2023 Financial Results
February 29, 2024
Provides Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Performance
YTD
+3.05%
+3.05%
1 Month
+4.26%
+4.26%
3 Month
-0.11%
-0.11%
6 Month
+24.95%
+24.95%
1 Year
-25.06%
-25.06%
More News
Read More
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
February 01, 2024
From
Certara
Via
GlobeNewswire
Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies
January 30, 2024
Via
Benzinga
Recap: Certara Q3 Earnings
November 08, 2023
Via
Benzinga
The Latest Analyst Ratings for Certara
October 11, 2023
Via
Benzinga
The Latest Analyst Ratings for Certara
August 11, 2023
Via
Benzinga
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
December 13, 2023
From
Certara
Via
GlobeNewswire
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
November 21, 2023
From
Certara
Via
GlobeNewswire
Looking Into Certara's Return On Capital Employed
May 22, 2023
Via
Benzinga
Analyst Expectations for Certara's Future
April 12, 2023
Via
Benzinga
Certara Reports Third Quarter 2023 Financial Results
November 08, 2023
From
Certara
Via
GlobeNewswire
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
October 11, 2023
From
Certara
Via
GlobeNewswire
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
September 19, 2023
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
August 29, 2023
From
Certara
Via
GlobeNewswire
Certara Simcyp™ Group Awarded Two New Grants from US FDA
August 29, 2023
From
Certara
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
August 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 10, 2023
Via
Benzinga
Certara Reports Second Quarter 2023 Financial Results
August 09, 2023
From
Certara
Via
GlobeNewswire
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
July 13, 2023
From
Certara
Via
GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
June 02, 2023
From
Certara
Via
GlobeNewswire
Certara Reports First Quarter 2023 Financial Results
May 08, 2023
From
Certara
Via
GlobeNewswire
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
April 27, 2023
From
Certara
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.